09/01/2021 / By Ralph Flores
Clay Clark investigates proven treatments for the Wuhan coronavirus (COVID-19) – and why hospitals aren’t even considering them – in the latest episode of the Thrive Time Show on Brighteon.TV.
In this episode, Clark talked to people who have received effective and affordable treatments for COVID-19.
“I started out with ivermectin, hydroxychloroquine, and then I later ordered the budesonide because I had some tightness in,” said one guest, who was recently treated for COVID-19. She went to an integrative health provider, which provided her with medicines that she can find in her local pharmacy.
“So let’s just be clear that 100% effective and affordable COVID-19 treatments include budesonide, ivermectin and hydroxychloroquine,” Clark added. “Those work – whether you’re a member of my team, or you’re somebody watching but the hospitals are denying access to patients that are seeking these treatments.”
However, Clark mentions that hospitals will not provide these treatments, as this goes against the protocols they received from the Centers for Disease Control and Prevention (CDC). The CDC’s current clinical management protocol lists remdesivir for treating moderate to severe COVID-19 infection. It’s worth noting that remdesivir got the green light from the Food and Drug Administration (FDA), despite multiple studies saying that it does not lower mortality rates. (Related: FDA greenlights remdesivir for treating coronavirus despite scientific data saying otherwise.)
Aside from remdesivir, the CDC also recommends dexamethasone, another highly controversial drug. A study from the National Institutes of Health revealed dexamethasone treatments resulted in the death of around one in five COVID-19 patients enrolled in the study, all of whom were in supplemental oxygen.
“[Affordable treatment] goes against the protocols that the Centers for Disease Control recommends, which is largely controlled by Bill Gates and his funding,” he added.
Clark also talked to an integrative health provider, who revealed that many COVID-19 patients inquire about these treatments.
“The problem is when people contact me, they’re already in the hospital, or a lot of times they’re in the ICU,” he explained.
Despite these treatments being effective and inexpensive, patients admitted to hospitals are denied access to these treatments. Instead, they are getting synthetic and dangerous treatments, per protocol. Mainstream media and so-called scientists, in fact, have continually tried to discredit hydroxychloroquine and its benefits, saying that it does not help with COVID-19. A recent comment in The American Journal of Medicine doubled down on this claim, saying that there is “some suggestion of harm.” (Related: Why are leftists hellbent on politicizing hydroxychloroquine?)
“The people who are going to the hospital because they have COVID-19, which is an upper respiratory infection caused by getting a gain of function man-made synthetic virus in their body,” said Clark. “In fact, they’re being treated with remdesivir and midazolam, which cause renal failure.
During the show, he also interviewed a family devastated by hospital policies on COVID-19 treatment. For the Meyer family, this caused the death of the father, leaving his wife Joni and daughter Miranda to deal with the loss. Joni recounted how she had to fight to put her husband on different treatments.
The attending physician told her that he didn’t know these studies and insisted that budesonide may harm his husband.
“That’s a lie … that’s a total lie,” said a visibly exasperated Clark.
Watch the full episode here.
Watch the Thrive Time Show weekdays, 3:00 p.m. on Brighteon.TV.
Sources include:
Tagged Under:
CDC, coronavirus, emergency use approval, FDA, pandemic, remdesivir
This article may contain statements that reflect the opinion of the author
Natural.News is a fact-based public education website published by Natural News Features, LLC.
All content copyright © 2018 by Natural News Features, LLC.
Contact Us with Tips or Corrections
All trademarks, registered trademarks and servicemarks mentioned on this site are the property of their respective owners.